A correctable immune niche for epithelial stem cell reprogramming and post-viral lung diseases.
Wu K, Zhang Y, Yin-DeClue H, Sun K, Mao D, Yang K, Austin SR, Crouch EC, Brody SL, Byers DE, Hoffmann CM, Hughes ME, Holtzman MJ.
Wu K, et al. Among authors: hoffmann cm.
J Clin Invest. 2024 Jul 25;134(18):e183092. doi: 10.1172/JCI183092.
J Clin Invest. 2024.
PMID: 39052353
Free PMC article.